Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib Anneleen DaemenDenise M. WolfJames E. KorkolaObi L. Griffith • Jessica R. FrankumRachel BroughLakshmi R. JakkulaNicholas J. Wang • Rachael NatrajanJorge S. Reis-FilhoChristopher J. LordAlan Ashworth • Paul T. SpellmanJoe W. GrayLaura J. van't Veer